Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Johnson & Johnson

NYSE: JNJHealthcare / Drug Manufacturers - Major / USA
137.52-1.00-0.72%Vol 10 130 6031Y Perf 7.67%
Apr 18th, 2019 16:00
BID0.0000 ASK0.0000
Open139.35 Previous Close138.52
Pre-Market- After-Trading137.52
 - -%  - -%
Target Price
144.00 
Analyst Rating
Moderate Buy 2.23
Potencial %
4.71 
Finscreener Ranking
★★     45.66
Insiders Trans % 3/6/12M
-/-50/-57 
Value Ranking
★★+     49.77
Insiders Value % 3/6/12M
-/-99/-99 
Growth Ranking
★★★★     58.06
Insiders Shares Cnt. % 3/6/12M
-/-99/-99 
Income Ranking
★★★     48.42
Market Cap (mil)368 953 
Earnings Rating
Sell
Price Range Ratio 52wk %
62.23 
Earnings Date
16th Apr 2019

Today's Price Range

135.75140.24

52wk Range

118.62148.99

5 Year PE Ratio Range

14.30310.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
0.17%
3 Months
5.23%
6 Months
-1.10%
1 Year
7.67%
3 Years
22.76%
5 Years
46.00%

Name / TickerPriceChg.Chg.%
JNJ137.52-1.0000-0.72
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
 
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.10
Current Ratio
1.50
Long Term Debt to Total Capital
0.32
Total Debt to Equity
0.51
Interest Coverage
18.90
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
66.80
EBIT Margin
23.30
EBITDA Margin
31.80
Pre-tax Profit Margin
24.20
Profit Margin
17.75
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
61 572 000
Revenue per Share
23.12
Revenue Growth 3 Years
5.26
Revenue Growth 5 Years
2.14
DividendsValueIndustryS&P 500US Markets
Dividend Yield
2.64
Dividend Rate
3.60
Dividend Growth 3 Years
6.18
Dividend Growth 5 Years
6.43

Earnings HistoryEstimateReportedSurprise %
Q01 20192.032.103.45
Q04 20181.951.971.03
Q03 20182.032.050.99
Q02 20182.062.101.94
Q01 20182.012.062.49
Q04 20171.721.741.16
Q03 20171.801.905.56
Q02 20171.791.832.23
Earnings Per EndEstimateRevision %Trend
3/2019 QR2.03-6.02Negative
6/2019 QR2.373.95Positive
12/2019 FY8.58-0.58Negative
12/2020 FY9.19-0.97Negative
Next Report Date-
Estimated EPS Next Report2.03
Estimates Count8
EPS Growth Next 5 Years %7.60
Volume Overview
Volume10 130 603
Shares Outstanding (in ths.)2 682 902
Trades Count43 697
Dollar Volume1 118 064 924
Avg. Volume6 895 349
Avg. Weekly Volume7 954 914
Avg. Monthly Volume6 013 583
Avg. Quarterly Volume6 746 625

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

25%75%

Bearish Bullish

53%47%

Bearish Bullish

49%51%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (30.77 %)
4 (30.77 %)
4 (33.33 %)
Moderate Buy
2 (15.38 %)
2 (15.38 %)
2 (16.67 %)
Hold
7 (53.85 %)
7 (53.85 %)
6 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.23
Moderate Buy
2.23
Moderate Buy
2.17

There are no comments yet.

News